Safe Orthopedics announces the 20,000th kit sold and the
Safe Orthopedics announces 20,000e kit sold and the success of the Sycamore evaluation phase
Ãragny-sur-Oise, Fleurieux-sur-l’Arbresle, November 25, 2021 at 5:45 p.m. CET – Safe Orthopedics (FR0013467123 – ALSAF), a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particularly safe for emergency vertebral fractures, announces the
20,000e kit sold, and the successful evaluation phase of Sycamore, the new treatment for vertebral compression fracture (VCF).
First, Safe Orthopedics has successfully reached the mark of 20,000 instrument kits sold worldwide. As a result of this achievement, many patients have been successfully treated using Safe Orthopedics’ proprietary out-of-the-box technology that offers significant benefits to the hospital, the surgical team and the patient.
On this subject, Nik Beyer, Commercial Director of Safe Orthopedics says: âDespite significant headwinds in the market, I am delighted that, through the hard work and determination of our direct sales teams, distribution partners and support teams, we have continued to prove that there is a real and growing unmet need for our technology to use in the global spine market.
Second, thanks to close collaboration with surgeons in France and Germany, Safe Orthopedics is coming to the end of a successful evaluation phase for its new treatment for vertebral compression fracture (VCF), Sycamore. Once this phase is completed, Sycamore is ready to be launched in early 2022 in certain markets.
Nik Beyer comments: âSycamore is an exciting product for our portfolio, a new concept in the market that promises to generate significant growth through 2022 and beyond in a VCF market that continues to show year-over-year growth. Market trends have shown us that the solutions available to surgeons to manage these difficult-to-treat patients do not always achieve the best results, Sycamore is designed to meet these demands â.
Pierre Dumouchel, Chairman and CEO of Safe Group concludes: âIt is with great pride that we make this announcement today. Our goal has always been to provide the best possible patient outcomes and it is a privilege to have contributed to the optimal treatment of so many patients. Taking this step under difficult market conditions, during a pandemic, and following up on a major component of product development at Sycamore is a testament to the investment we have made in our business and innovation units and working partnerships. relationships that we have with our expert surgeons. For patients with CVF, long-term fracture correction is essential to achieve the best patient outcomes. Our Sycamore implant is designed to deliver just that â.
About the Safe Group
Safe Group is a French medical technology group which brings together Safe Orthopedics, a pioneer in ready-to-use technologies for spinal pathologies, and Safe Medical (formerly LCI Medical), a subcontractor of medical devices for orthopedic surgery. The group employs around 150 people.
Safe Orthopedics develops and manufactures kits combining sterile implants and single-use instruments, available to the surgeon at any time. These technologies are part of a minimally invasive approach aimed at reducing the risks of contamination and infection, for the benefit of the patient and with a positive impact on the delays and costs of hospitalization. Protected by 18 patent families, SteriSpineTM kits are CE marked and FDA approved. Safe Orthopedics is headquartered in the Paris region (Eragny-sur-Oise (95610)) and has subsidiaries in the United Kingdom, Germany, the United States and in the Lyon region (Fleurieux-sur-l’Arbresle).
For more information: www.safeorthopaedics.com
Safe Medical produces implantable medical devices and ready-to-use instruments. It has an innovation center and two production sites in France (Fleurieux-sur-l’Arbresle, 69210) and Tunisia, offering a wide range of industrial services: design, industrialization, machining, finishing and sterile packaging. . Supported by the French recovery plan in 2020, the company is investing in additive printing and will be operational in 2022 on this new technology.
For more information: www.safemedical.fr
Financial and Administrative Director
Phone. : +33 (0) 1 34 21 50 00
PR- 20,000 Sycamore vdef kits